Pharmaceutical and Life Sciences Real World Evidence, 2020-2030: Distribution by Type of Applications, Type of Real World Data Sources, Therapeutic Area, and Geography – GlobeNewswire

CONTEXT:  Commercial announcement of an RWE report updated for 2020 to 2030 claiming to cover a wide range of information about providers of RWE services and future trends in RWE. Continue Reading

Posted On :

Outcomes in PF-ILD Not Due to IPF Equally Poor, Real-World Study Finds – Pulmonary Fibrosis News

CONTEXT:  Relatively small scale retrospective analysis of IPF patients in Japan reveals outcomes are poor for patients developing progressive fibrosing interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF).    IMPACT:  Low Continue Reading

Posted On :

New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis – Yahoo Finance

CONTEXT:  Report from the American Academy of Neurology on Biogen’s main two MS compounds, with RWE showing value on detecting patient QoL and overall treatment preferences. READ TIME:  2 mins Quality Level Continue Reading

Posted On :

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients – Yahoo Finance

CONTEXT:  On the back of previous news stories about genetic biomarker testing in NSCLC, Neogenomics announces the launch of KRAS G12C testing to eligible advanced / late stage NSCLC cancer Continue Reading

Posted On :

New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection and Reduction of Migraine Burden Presented at 2021 American Academy of Neurology Virtual Annual Meeting – Business Wire

CONTEXT:  It seems that having Real-World Data (capitalised for emphasis) alongside your traditional clinical data at a poster presentation now adds weight to the overall message.  RWR is the must-have Continue Reading

Posted On :